-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-3 Addressing Toxicities Following Cellular Therapy

Program: Scientific Program
Session: Challenges in Cell Therapy: Relapse and Toxicities
Saturday, December 5, 2020, 9:25 AM-9:30 AM

Chiara Bonini, MD

Ospedale San Raffaele, Milano, Italy

Disclosures: Bonini: Kiadis: Membership on an entity's Board of Directors or advisory committees; Allogene: Membership on an entity's Board of Directors or advisory committees; Intellia Therapeutics: Membership on an entity's Board of Directors or advisory committees, Patents & Royalties, Research Funding; Kite/Gilead: Membership on an entity's Board of Directors or advisory committees; Molmed: Membership on an entity's Board of Directors or advisory committees.

See more of: Challenges in Cell Therapy: Relapse and Toxicities
See more of: Scientific Program
<< Previous Presentation | Next Presentation